Microfluidic Immune Modeling Device for Hypersensitivity Prediction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for testing the immune response to substances, such as cosmetics and chemicals, rely on animal testing, which is unethical and inefficient, and lack a reliable in vitro alternative for predicting hypersensitivity reactions.
Innovation Solution
An immune modeling device with a barrier component and an immune component connected by microfluidics, allowing for the culture of biological barriers and immune cells, and enabling the monitoring of immune reactions, including dendritic cell migration and T-cell proliferation, to assess the potential for hypersensitivity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If animal testing is used to test immune response to substances, then reliable prediction of hypersensitivity reactions can be achieved, but ethical concerns arise and the method is inefficient
Solution Approach 1:
The immune system is segmented into distinct functional components (barrier component, immune component with dendritic cells and T cells) that are cultured separately in microfluidic chambers but maintain physiological interactions through controlled fluid flow, enabling ethical in vitro testing while preserving predictive reliability
Solution Approach 2:
A microfluidic system acts as an intermediary that recreates the physiological interface between barrier tissues and immune cells, allowing substances to be tested on human-derived cells in a controlled environment that mimics in vivo conditions without requiring animal subjects
2Object-affected harmful factors
If traditional in vitro methods are used, then ethical concerns are avoided, but they lack reliability in predicting immune reactions and hypersensitivity
Solution Approach 1:
Multiple cell types (barrier cells, dendritic cells, T cells) that are normally distributed throughout tissue are merged into a functional in vitro system with microfluidic connections, recreating the spatial and functional relationships necessary for reliable immune response prediction while maintaining ethical in vitro standards
Solution Approach 2:
Microfluidic channels use controlled fluid flow to mimic physiological conditions, enabling nutrients, cytokines, and test substances to be delivered to cell cultures in a manner that reproduces in vivo transport mechanisms and enhances the reliability of immune reaction predictions
3Loss of information
If complex immune system interactions are studied in detail, then understanding of hypersensitivity improves, but device complexity increases
Solution Approach 1:
The complex immune system is segmented into manageable functional modules (barrier component, immune component with specific cell types) that can be independently cultured and then reassembled in controlled configurations, enabling detailed study of immune interactions while maintaining device manageability through modular design
Solution Approach 2:
The device transitions from two-dimensional cell cultures to a three-dimensional microfluidic environment with vertical fluid flow and spatially distributed cell chambers, enabling more physiologically relevant immune cell interactions while maintaining compact device footprint through efficient use of vertical space
Data Source
AI summary
Devices and methods are provided for detecting an immune reaction to a test agent using an immune modeling system comprising a barrier component configured to culture a biological barrier, an immune component configured to culture immune cells, and one or more inter-component microfluidic connections between the barrier component and the immune component. The system provides for culturing a biological barrier in the barrier component of the system, culturing immune cells in the immune component of the system, applying the test agent to the biological barrier, and monitoring the immune cells to detect an immune reaction to the test agent.